Editorial
doi: 10.1080/14760584.2022.2117692.
Epub 2022 Sep 1.
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza
Affiliations
- PMID: 36004567
- DOI: 10.1080/14760584.2022.2117692
Item in Clipboard
Editorial
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza
Expert Rev Vaccines.
2022 Nov.
No abstract available
Keywords: COVID-19; Influenza; SARS-CoV-2; bivalent vaccine; coinfection; viral vectored vaccine.
Similar articles
-
SARS-CoV-2 Vaccine Strain Selection: Guidance From Influenza.J Infect Dis. 2022 Dec 28;227(1):4-8. doi: 10.1093/infdis/jiac454. J Infect Dis. 2022. PMID: 36424890 Free PMC article.
-
A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.EBioMedicine. 2022 Nov;85:104297. doi: 10.1016/j.ebiom.2022.104297. Epub 2022 Oct 4. EBioMedicine. 2022. PMID: 36206623 Free PMC article.
-
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters.Nat Commun. 2023 Jul 11;14(1):4117. doi: 10.1038/s41467-023-39560-9. Nat Commun. 2023. PMID: 37433761 Free PMC article.
-
The new generation of messenger RNA (mRNA) vaccines against influenza.Enferm Infecc Microbiol Clin (Engl Ed). 2023 May;41(5):301-304. doi: 10.1016/j.eimce.2022.07.006. Epub 2022 Jul 26. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 35906174 Free PMC article. Review.
-
[Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Feb 6;56(2):103-107. doi: 10.3760/cma.j.cn112150-20211203-01117. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 34954956 Review. Chinese.
Cited by
-
The effect of SARS-CoV-2 double vaccination on the outcomes of hemodialysis patients with COVID-19: A meta-analysis.J Infect. 2023 Feb;86(2):e43-e45. doi: 10.1016/j.jinf.2022.09.022. Epub 2022 Sep 26. J Infect. 2023. PMID: 36174838 Free PMC article. No abstract available.
-
Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines.Front Immunol. 2025 Jun 25;16:1578733. doi: 10.3389/fimmu.2025.1578733. eCollection 2025. Front Immunol. 2025. PMID: 40636108 Free PMC article. Review.
-
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters.Vaccines (Basel). 2024 Nov 21;12(12):1300. doi: 10.3390/vaccines12121300. Vaccines (Basel). 2024. PMID: 39771962 Free PMC article.
-
Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections.Vaccines (Basel). 2025 Mar 21;13(4):335. doi: 10.3390/vaccines13040335. Vaccines (Basel). 2025. PMID: 40333234 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
